45 related articles for article (PubMed ID: 34471053)
1. Pharmacological Inhibition of MCT4 Reduces 4-Hydroxytamoxifen Sensitivity by Increasing HIF-1α Protein Expression in ER-Positive MCF-7 Breast Cancer Cells.
Nadai T; Narumi K; Furugen A; Saito Y; Iseki K; Kobayashi M
Biol Pharm Bull; 2021; 44(9):1247-1253. PubMed ID: 34471053
[TBL] [Abstract][Full Text] [Related]
2. A molecular model for the mechanism of acquired tamoxifen resistance in breast cancer.
Fan P; Agboke FA; Cunliffe HE; Ramos P; Jordan VC
Eur J Cancer; 2014 Nov; 50(16):2866-76. PubMed ID: 25204804
[TBL] [Abstract][Full Text] [Related]
3. Berberine Reverses Hypoxia-induced Chemoresistance in Breast Cancer through the Inhibition of AMPK- HIF-1α.
Pan Y; Shao D; Zhao Y; Zhang F; Zheng X; Tan Y; He K; Li J; Chen L
Int J Biol Sci; 2017; 13(6):794-803. PubMed ID: 28656004
[TBL] [Abstract][Full Text] [Related]
4. Baicalein resensitizes tamoxifen-resistant breast cancer cells by reducing aerobic glycolysis and reversing mitochondrial dysfunction via inhibition of hypoxia-inducible factor-1α.
Chen Y; Zhang J; Zhang M; Song Y; Zhang Y; Fan S; Ren S; Fu L; Zhang N; Hui H; Shen X
Clin Transl Med; 2021 Nov; 11(11):e577. PubMed ID: 34841716
[TBL] [Abstract][Full Text] [Related]
5. Aerobic exercise-induced HIF-1α upregulation in heart failure: exploring potential impacts on MCT1 and MPC1 regulation.
Xu L; Yang M; Wei A; Wei Z; Qin Y; Wang K; Li B; Chen K; Liu C; Li C; Wang T
Mol Med; 2024 Jun; 30(1):83. PubMed ID: 38867145
[TBL] [Abstract][Full Text] [Related]
6. Identification of gene regulation patterns underlying both oestrogen- and tamoxifen-stimulated cell growth through global gene expression profiling in breast cancer cells.
Fan P; Cunliffe HE; Griffith OL; Agboke FA; Ramos P; Gray JW; Jordan VC
Eur J Cancer; 2014 Nov; 50(16):2877-86. PubMed ID: 25212499
[TBL] [Abstract][Full Text] [Related]
7. Imaging breast cancer using hyperpolarized carbon-13 MRI.
Gallagher FA; Woitek R; McLean MA; Gill AB; Manzano Garcia R; Provenzano E; Riemer F; Kaggie J; Chhabra A; Ursprung S; Grist JT; Daniels CJ; Zaccagna F; Laurent MC; Locke M; Hilborne S; Frary A; Torheim T; Boursnell C; Schiller A; Patterson I; Slough R; Carmo B; Kane J; Biggs H; Harrison E; Deen SS; Patterson A; Lanz T; Kingsbury Z; Ross M; Basu B; Baird R; Lomas DJ; Sala E; Wason J; Rueda OM; Chin SF; Wilkinson IB; Graves MJ; Abraham JE; Gilbert FJ; Caldas C; Brindle KM
Proc Natl Acad Sci U S A; 2020 Jan; 117(4):2092-2098. PubMed ID: 31964840
[TBL] [Abstract][Full Text] [Related]
8. MCT4 knockdown by tumor microenvironment-responsive nanoparticles remodels the cytokine profile and eradicates aggressive breast cancer cells.
Abdellatif AAH; Bouazzaoui A; Tawfeek HM; Younis MA
Colloids Surf B Biointerfaces; 2024 Jun; 238():113930. PubMed ID: 38692174
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of monocarboxylate transporters (MCT) 1 and 4 reduces exercise capacity in mice.
Kitaoka Y; Takahashi K; Hatta H
Physiol Rep; 2022 Sep; 10(17):e15457. PubMed ID: 36065874
[TBL] [Abstract][Full Text] [Related]
10. Crosstalk between hydroxytyrosol, a major olive oil phenol, and HIF-1 in MCF-7 breast cancer cells.
Calahorra J; Martínez-Lara E; Granadino-Roldán JM; Martí JM; Cañuelo A; Blanco S; Oliver FJ; Siles E
Sci Rep; 2020 Apr; 10(1):6361. PubMed ID: 32286485
[TBL] [Abstract][Full Text] [Related]
11. Lactate in breast cancer cells is associated with evasion of hypoxia-induced cell cycle arrest and adverse patient outcome.
Liu Y; Suhail Y; Novin A; Afzal J; Pant A; Kshitiz
Hum Cell; 2024 May; 37(3):768-781. PubMed ID: 38478356
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of COL11A1 confers tamoxifen resistance in breast cancer.
Fu C; Duan S; Zhou X; Meng Y; Chen X
NPJ Breast Cancer; 2024 May; 10(1):38. PubMed ID: 38806505
[TBL] [Abstract][Full Text] [Related]
13. Identification of hypoxia-induced metabolism-associated genes in canine tumours.
Kato T; Sakurai M; Watanabe K; Mizukami Y; Nakagawa T; Baba K; Mizuno T; Igase M
Vet Comp Oncol; 2024 May; ():. PubMed ID: 38712488
[TBL] [Abstract][Full Text] [Related]
14. Milking the stroma in triple-negative breast cancer.
Thompson AM; Newman TJ
Cell Cycle; 2012 Apr; 11(8):1487. PubMed ID: 22544077
[TBL] [Abstract][Full Text] [Related]
15. FGFR1β is a driver isoform of FGFR1 alternative splicing in breast cancer cells.
Zhao M; Zhuo ML; Zheng X; Su X; Meric-Bernstam F
Oncotarget; 2019 Jan; 10(1):30-44. PubMed ID: 30713601
[TBL] [Abstract][Full Text] [Related]
16. 5-Oxoproline Enhances 4-Hydroxytamoxifen-induced Cytotoxicity by Increasing Oxidative Stress in MCF-7 Breast Cancer Cells.
Nadai T; Narumi K; Mukai Y; Ueda H; Furugen A; Saito Y; Kobayashi M
Anticancer Res; 2023 Mar; 43(3):1113-1120. PubMed ID: 36854517
[TBL] [Abstract][Full Text] [Related]
17. 3-Bromopyruvate-mediated MCT1-dependent metabolic perturbation sensitizes triple negative breast cancer cells to ionizing radiation.
Skaripa-Koukelli I; Hauton D; Walsby-Tickle J; Thomas E; Owen J; Lakshminarayanan A; Able S; McCullagh J; Carlisle RC; Vallis KA
Cancer Metab; 2021 Oct; 9(1):37. PubMed ID: 34649623
[TBL] [Abstract][Full Text] [Related]
18. CISD2 Promotes Resistance to Sorafenib-Induced Ferroptosis by Regulating Autophagy in Hepatocellular Carcinoma.
Li B; Wei S; Yang L; Peng X; Ma Y; Wu B; Fan Q; Yang S; Li X; Jin H; Tang S; Huang M; Li H; Liu J
Front Oncol; 2021; 11():657723. PubMed ID: 34485112
[TBL] [Abstract][Full Text] [Related]
19. Development of selective HDAC6 inhibitors with in vitro and in vivo anti-multiple myeloma activity.
Li S; Zhao C; Zhang G; Xu Q; Liu Q; Zhao W; James Chou C; Zhang Y
Bioorg Chem; 2021 Nov; 116():105278. PubMed ID: 34474303
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
